David M. Hinkle

886 total citations
29 papers, 568 citations indexed

About

David M. Hinkle is a scholar working on Ophthalmology, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, David M. Hinkle has authored 29 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Ophthalmology, 6 papers in Epidemiology and 4 papers in Clinical Biochemistry. Recurrent topics in David M. Hinkle's work include Ocular Diseases and Behçet’s Syndrome (12 papers), Ocular Infections and Treatments (7 papers) and Retinal and Optic Conditions (6 papers). David M. Hinkle is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (12 papers), Ocular Infections and Treatments (7 papers) and Retinal and Optic Conditions (6 papers). David M. Hinkle collaborates with scholars based in United States, Canada and France. David M. Hinkle's co-authors include C. Stephen Foster, Gary E. Borodic, Gian Paolo Giuliari, Tahreem A. Mir, Ama Sadaka, E. Rand Simpson, Frederick W. Fraunfelder, David Zurakowski, M. Mulhern and Marian S. Macsai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Emerging infectious diseases and American Journal of Ophthalmology.

In The Last Decade

David M. Hinkle

28 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David M. Hinkle United States 14 372 96 93 82 61 29 568
Christos Kalogeropoulos Greece 14 692 1.9× 105 1.1× 192 2.1× 28 0.3× 93 1.5× 37 883
Shailaja Valluri United States 19 403 1.1× 126 1.3× 260 2.8× 52 0.6× 151 2.5× 31 778
H Savir Israel 13 376 1.0× 97 1.0× 214 2.3× 36 0.4× 78 1.3× 59 590
Chrysanthos Symeonidis Greece 14 717 1.9× 88 0.9× 259 2.8× 17 0.2× 84 1.4× 52 878
Israel Kremer Israel 17 297 0.8× 158 1.6× 440 4.7× 34 0.4× 37 0.6× 33 644
Raul N. G. Vianna Brazil 13 354 1.0× 50 0.5× 78 0.8× 11 0.1× 49 0.8× 47 483
H Verbraeken Belgium 15 443 1.2× 58 0.6× 150 1.6× 27 0.3× 26 0.4× 57 579
Krishna R. Murthy India 11 202 0.5× 60 0.6× 140 1.5× 8 0.1× 74 1.2× 26 376
Jin Kwon Chung South Korea 13 243 0.7× 58 0.6× 174 1.9× 27 0.3× 40 0.7× 44 439
Lawrence Lee Australia 12 297 0.8× 70 0.7× 239 2.6× 26 0.3× 44 0.7× 40 463

Countries citing papers authored by David M. Hinkle

Since Specialization
Citations

This map shows the geographic impact of David M. Hinkle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Hinkle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Hinkle more than expected).

Fields of papers citing papers by David M. Hinkle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Hinkle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Hinkle. The network helps show where David M. Hinkle may publish in the future.

Co-authorship network of co-authors of David M. Hinkle

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Hinkle. A scholar is included among the top collaborators of David M. Hinkle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Hinkle. David M. Hinkle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thompson, Krista A., Bita Momenaei, Thomas F. Jenkins, et al.. (2025). Visual Outcomes in Cases of Endogenous Endophthalmitis. Ophthalmology Retina. 10(1). 61–70.
2.
Odom, J. Vernon, et al.. (2024). Autosomal Dominant Retinitis Pigmentosa Secondary to TOPORS Mutations: A Report of a Novel Mutation and Clinical Findings. Journal of Clinical Medicine. 13(5). 1498–1498. 2 indexed citations
3.
Harvey, Justin, et al.. (2023). Ocular syphilis on the rise: a 10-year analysis from 2010 to 2020. International Ophthalmology. 43(12). 4419–4426. 5 indexed citations
4.
Lee, Chang Sup, et al.. (2022). The microbiological spectrum, antimicrobial resistance pattern, and visual outcomes of endogenous endophthalmitis in West Virginia 2009–2019. International Ophthalmology. 42(10). 3153–3163. 4 indexed citations
5.
Lee, Chang Sup, et al.. (2021). Mortality risk associated with endophthalmitis in West Virginia. International Ophthalmology. 41(8). 2887–2895. 3 indexed citations
6.
Mir, Tahreem A., et al.. (2020). Trends in Infantile Endogenous Endophthalmitis Hospitalizations in the United States. Ophthalmology Retina. 4(11). 1109–1117. 3 indexed citations
7.
Schechet, Sidney A., et al.. (2020). Syphilitic retinitis presentations: punctate inner retinitis and posterior placoid chorioretinitis. International Ophthalmology. 41(1). 211–219. 8 indexed citations
8.
Mir, Tahreem A., et al.. (2019). Acute Vascular Ischemic Events in Patients With Central Retinal Artery Occlusion in the United States: A Nationwide Study 2003-2014. American Journal of Ophthalmology. 200. 179–186. 49 indexed citations
9.
Hinkle, David M., et al.. (2017). Moxifloxacin Concentration and Proteomic Analysis of Aqueous Humor in Human Uveitis Associated with Oral Moxifloxacin Therapy. The Open Ophthalmology Journal. 11(1). 107–116. 4 indexed citations
10.
Hinkle, David M., et al.. (2014). Human Papilloma Virus Vaccine Associated Uveitis. Current Drug Safety. 9(1). 65–68. 29 indexed citations
11.
Arcinue, Cheryl A., et al.. (2013). ACUTE UNILATERAL TOXOPLASMA RETINOCHOROIDITIS ASSOCIATED WITH ADALIMUMAB, A TUMOR NECROSIS FACTOR-α ANTAGONIST. Retinal Cases & Brief Reports. 7(2). 152–154. 7 indexed citations
12.
Giuliari, Gian Paolo, Ama Sadaka, & David M. Hinkle. (2013). Biologic agents in experimental autoimmune uveitis. International Ophthalmology. 34(1). 145–156. 5 indexed citations
13.
Borodic, Gary E., et al.. (2011). Drug-Induced Graves Disease From CTLA-4 Receptor Suppression. Ophthalmic Plastic and Reconstructive Surgery. 27(4). e87–e88. 93 indexed citations
14.
Hinkle, David M., Efrem D. Mandelcorn, Partho S. Kalyani, et al.. (2011). Bilateral uveitis associated with fluoroquinolone therapy. Cutaneous and Ocular Toxicology. 31(2). 111–116. 43 indexed citations
15.
Giuliari, Gian Paolo, Ama Sadaka, David M. Hinkle, & E. Rand Simpson. (2010). Current treatments for radiation retinopathy. Acta Oncologica. 50(1). 6–13. 46 indexed citations
17.
Giuliari, Gian Paolo, David M. Hinkle, & C. Stephen Foster. (2009). Local Treatment for Lymphoid Malignancies of the Eye. Anti-Cancer Agents in Medicinal Chemistry. 9(10). 1123–1128. 10 indexed citations
18.
Hinkle, David M. & C. Stephen Foster. (2008). Tubulointerstitial Nephritis and Uveitis Syndrome. International Ophthalmology Clinics. 48(2). 9–13. 13 indexed citations
19.
Macsai, Marian S., et al.. (2001). Tyrosinemia type II: nine cases of ocular signs and symptoms. American Journal of Ophthalmology. 132(4). 522–527. 60 indexed citations
20.
Kundin, W. D., et al.. (1972). A Serologic Survey of Military Personnel and Dogs in Thailand and South Vietnam for Antibodies to Arboviruses, Rickettsia tsutsugamushi, and Pseudomonas pseudomallei. American Journal of Veterinary Research. 33(10). 2091–2095. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026